Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate vs dexmedetomidine as adjuvant to ropivacaine in erector spinae block for mastectomy
2025-523152-31-00Phase 4Authorised
- Sponsor
- Foundation for the Incentive of Research
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in breast cancer and postoperative pain comparing Ropivacaine + dexmedetomidine with Ropivacaine + magnesium sulfate (2 arms). Planned start Jan 2026; status: authorised.
02
Drugs
dexmedetomidinemagnesium sulfateropivacaine
03
Conditions
breast cancerpostoperative pain
Beyond the preview
Go deeper on 2025-523152-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523152-31-00.